Breaking News Novavax’ Traditional Vaccine Brings Imminent Competition to the Genetic-based Vaccines Currently Under EUA

Breaking News Novavax’ Traditional Vaccine Brings Imminent Competition to the Genetic-based Vaccines Currently Under EUA

U.S-based Novavax (Nasdaq: NVAX) reports today that its COVID-19 vaccine candidate called NVX-CoV2373 or “Coronavax” demonstrated 100% protection against moderate and severe disease and 90.4% overall efficacy, keeping this investigational product competitive with both mRNA-based vaccine products under emergency use authorization (EUA) as well as superior to the Johnson and Johnson Adenovirus-based vaccine, which is also authorized for deployment in the USA on an emergency basis. NVX-CoV2373 is a recombinant nanoparticle protein-based experimental vaccine, and could become the first vaccine available in the USA that does not use a gene therapy-based vaccination method. Meeting its clinical trial endpoints during the PREVENT-19 pivotal Phase 3 clinical trial, this study included 29,260 participants across 119 trial site organizations in both America and Mexico.  The PREVENT-19 study evaluated the efficacy, safety, and immunogenicity of the Novavax candidate, and focused on the recruitment of study participants who are epidemiologically more likely to be impacted by the disease (e.g. the elderly, minorities, those with co-morbidities). But facing what is considered int...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee